EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A standardized Orthosiphon aristatus extract improves forced-swimming performance and modulates hematological and hepatic biochemical parameters in paclitaxel-treated mice

Fouad Saleih Resq Al-Suede, Nur Fitriyani Afiqah Abu Bakar, Rapidah Mohamad, Mohd Shahrul Ridzuan Hamil, Ashwaq Hamid Salem Yehya, Chern Ein Oon, Zurina Hassan, Aman Shah Abdul Majid, Amin Malik Shah Abdul Majid, Muhammad Asyraf Abduraman

Frontiers in Pharmacology · 02.11.2026 · 17

DOI: 10.3389/fphar.2026.1927335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.11.2026. Verfasst von Fouad Saleih Resq Al-Suede und 9 weiteren Autor:innen. Beteiligte Einrichtung: EMAN Biodiscoveries Sdn. Bhd., Sungai Petani, Kedah, Malaysia. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-related fatigue is a prevalent and debilitating condition among patients undergoing chemotherapy, markedly impairing quality of life and treatment adherence. This multifactorial syndrome arises from both the malignancy itself and treatment-related toxicities, particularly those associated with neurotoxic and cytotoxic agents such as paclitaxel. Despite its high prevalence, effective and well-tolerated interventions for chemotherapy-induced fatigue remain limited. The present study evaluated the effects of Lanctos 75™ (C5OSEW5050ESA), a standardized polymolecular extract derived from Orthosiphon aristatus (Blume) Miq., on chemotherapy-associated physical performance in paclitaxel-treated mice. Thirty adult male mice were allocated to five groups (n = 6 per group). Lanctos 75™ (200 or 400 mg/kg/day) or rosmarinic acid (30 mg/kg/day) was administered orally for 7 days before paclitaxel exposure (10 mg/kg/day for 5 days). Physical performance was assessed using a modified forced swimming test, together with clinical observations, body weight, food and water intake, hematological parameters, serum biochemistry, and qualitative histopathology. Lanctos 75™-treated mice showed improved forced-swimming performance compared with the paclitaxel-treated control group. Paclitaxel alone was associated with reduced body weight and WBC count and with alterations in serum globulin, glucose, AST, and ALT, whereas these parameters were less altered in the Lanctos 75™-treated groups. Rosmarinic acid also showed activity in selected measured outcomes. As the forced-swimming paradigm assesses only a component of physical performance under experimental stress, the observed improvement does not demonstrate reversal of the multidimensional clinical syndrome of cancer-related fatigue. However, the overall findings indicate that Lanctos 75™ was associated with improved forced-swimming performance and differences in selected hematological and biochemical parameters in paclitaxel-treated mice. These preclinical observations warrant confirmation in adequately powered studies using complementary fatigue-related behavioral measures and direct mechanistic assessments.

Schlagwörter

Stichwörter der Autor:innen

C5OSEW5050ESAOrthosiphon aristatus (Blume) Miq.chemotherapy-induced fatigueforced swimming testpaclitaxelpolymolecular botanical extract

Autor:innen und Institutionen

  • EMAN Biodiscoveries Sdn. Bhd., Sungai Petani, Kedah, Malaysia.
  • Center for Inflammatory Bowel Diseases, Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Gelugor, Penang, Malaysia.
  • Centre for Drug Research, Universiti Sains Malaysia, Gelugor, Penang, Malaysia.
  • Department of Pharmacology/Centre for Angiogenesis and Natural Product Research, Faculty of Medicine, Quest International University, Ipoh, Perak, Malaysia.
  • John Curtin School of Medical Research, College of Medicine, Australian National University, Canberra, ACT, Australia.

Zitieren

APA

Al-Suede, F. S. R., Abu Bakar, N. F. A., Mohamad, R., Hamil, M. S. R., Salem Yehya, A. H., Oon, C. E., Hassan, Z., Abdul Majid, A. S., Abdul Majid, A. M. S., & Abduraman, M. A. (2026). A standardized Orthosiphon aristatus extract improves forced-swimming performance and modulates hematological and hepatic biochemical parameters in paclitaxel-treated mice. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1927335

Vancouver

Al-Suede FSR, Abu Bakar NFA, Mohamad R, Hamil MSR, Salem Yehya AH, Oon CE, et al. A standardized Orthosiphon aristatus extract improves forced-swimming performance and modulates hematological and hepatic biochemical parameters in paclitaxel-treated mice. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1927335

BibTeX
@article{AlSuede2026,
  author = {Al-Suede, Fouad Saleih Resq and Abu Bakar, Nur Fitriyani Afiqah and Mohamad, Rapidah and Hamil, Mohd Shahrul Ridzuan and Salem Yehya, Ashwaq Hamid and Oon, Chern Ein and Hassan, Zurina and Abdul Majid, Aman Shah and Abdul Majid, Amin Malik Shah and Abduraman, Muhammad Asyraf},
  title = {A standardized Orthosiphon aristatus extract improves forced-swimming performance and modulates hematological and hepatic biochemical parameters in paclitaxel-treated mice},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1927335}
}
Kostenlos starten →